Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

PaperCitations, authors & open-access status

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 4,139 citations, 2005 year and green oa status.

4,139
Citations
2005
Year
green
OA Status

Related on ScholarIQ

Robert J. Heine
Author
The Lancet
Journal
Peroxisome Proliferator-Activated Receptors
Topic
Peroxisome Proliferator-Activated Receptors
Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Topic
Cardiovascular Function and Risk Factors
Topic
470M+ articles · free account